--- title: "Bayer Wins Legal Fight in Bid for $7.25 Billion Roundup Settlement Approval" type: "News" locale: "en" url: "https://longbridge.com/en/news/290133172.md" description: "Bayer AG won a legal fight that moves it closer to Missouri state court approval for a proposed $7.25 billion settlement covering thousands of US cancer lawsuits alleging its Roundup weedkiller caused cancer. According to Bloomberg, the ruling advances Bayer’s effort to resolve the litigation through the state court process." datetime: "2026-06-18T02:58:52.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/290133172.md) - [en](https://longbridge.com/en/news/290133172.md) - [zh-HK](https://longbridge.com/zh-HK/news/290133172.md) generator: "portal-rs" --- # Bayer Wins Legal Fight in Bid for $7.25 Billion Roundup Settlement Approval Bayer AG won a legal fight that moves it closer to Missouri state court approval for a proposed $7.25 billion settlement covering thousands of US cancer lawsuits alleging its Roundup weedkiller caused cancer. According to Bloomberg, the ruling advances Bayer’s effort to resolve the litigation through the state court process. ### Related Stocks - [BAYZF.US](https://longbridge.com/en/quote/BAYZF.US.md) - [BAYN.DE](https://longbridge.com/en/quote/BAYN.DE.md) - [BAYRY.US](https://longbridge.com/en/quote/BAYRY.US.md) ## Related News & Research - [BAYN: On track for above-market growth, margin expansion, and industry-leading innovation by 2029](https://longbridge.com/en/news/297795362.md) - [Bayer says Crop Science unit makes progress on product launches](https://longbridge.com/en/news/297781754.md) - [Weekly Recap: Eighth Circuit upholds Roundup and Kerendia Japan filing](https://longbridge.com/en/news/297465368.md) - [IBA to assess electron beam, Rhodotron technology for PFAS destruction under PFAROS initiative](https://longbridge.com/en/news/297733650.md) - [BAYN: Blockbuster launches, AI-driven R&D, and cost cuts drive strong growth and profitability targets](https://longbridge.com/en/news/297793707.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**